Amphastar Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Amphastar Pharmaceuticals,

11/03/2022 04:29

* Amphastar Pharmaceuticals Inc  AMPH.OQ  reported quarterly
adjusted earnings of 42 cents​​ per share for the quarter ended
in December. The mean expectation of six analysts for the
quarter was for earnings of 37 cents per share.
    * Revenue rose 26% to $120.89 million from a year ago; 
analysts
expected $111.44 million. 
    * Amphastar Pharmaceuticals Inc's reported EPS for the
quarter was
39 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.9%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Amphastar Pharmaceuticals Inc shares had risen by 29.2%
this
quarter.
    * The company reported quarterly net income of $19.76
million.
    * Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $31.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 11 at 04:29 a.m.  ​All
figures in US dollars unless otherwise stated